Atezolizumab Plus Chemotherapy for First-Line Treatment of Non-Squamous Non-Small Cell Lung Cancer: Results From the Randomized Phase III IMpower132 Trial

Lung, Respiratory and Thoracic Cancer
Do you want to read an article? Please log in or register.